Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer

US Patent 10864203 · Granted Dec 15, 2020

Estimated economic value: $146,803,000

Assignee

Inventors

View full patent text on Google Patents →